| JHJCX | RWMFX | JHJCX / RWMFX | |
| Total Expense Ratio | 1.87 | 0.31 | 603% |
| Annual Report Gross Expense Ratio | 2.08 | 0.31 | 671% |
| Fund Existence | 9 years | 24 years | - |
| Gain YTD | 6.293 | 8.905 | 71% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 118M | 204B | 0% |
| Annual Yield % from dividends | 0.00 | 1.41 | - |
| Returns for 1 year | -5.51 | 4.59 | -120% |
| Returns for 3 years | 31.03 | 29.92 | 104% |
| Returns for 5 years | 39.06 | 45.02 | 87% |
| Returns for 10 years | N/A | 72.75 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LICPX | 18.03 | N/A | N/A |
| Lord Abbett International Equity P | |||
| UOPIX | 137.35 | N/A | N/A |
| ProFunds UltraNASDAQ-100 Inv | |||
| CBGAX | 15.01 | N/A | N/A |
| ClearBridge Global Infrastructure Inc C | |||
| MSVEX | 6.28 | N/A | N/A |
| Morgan Stanley Vitality Portfolio A | |||
| JFNAX | 79.65 | -0.17 | -0.21% |
| Janus Henderson Global Life Sciences A | |||